Synthesis and anticancer activities of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives

European Journal of Medicinal Chemistry
2014.0

Abstract

Trying to develop potent and selective anticancer agents, two series of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives were designed and synthesized. Their antitumor activities were evaluated by MTT method against four selected human cancer cell lines (MGC-803, EC-9706, HeLa and MCF-7). Our results showed that compound 11h exhibited good anticancer activities compared to 5-fluorouracil against the four tested cell lines, with IC50 values ranging from 2.0 to 4.5 μM. Flow cytometry analysis indicated that compound 11h induced the cellular early apoptosis and cell cycle arrest at G2/M phase in EC-9706.

Knowledge Graph

Similar Paper

Synthesis and anticancer activities of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives
European Journal of Medicinal Chemistry 2014.0
Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents
European Journal of Medicinal Chemistry 2014.0
Synthesis and evaluation of anti-proliferative activity of 1,4-disubstituted phthalazines
Medicinal Chemistry Research 2012.0
Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents
European Journal of Medicinal Chemistry 2013.0
Design, synthesis and biological evaluation of novel 1,2,4-triazolo [3,4-b][1,3,4] thiadiazines bearing furan and thiophene nucleus
European Journal of Medicinal Chemistry 2015.0
Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones
European Journal of Medicinal Chemistry 2015.0
Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives
Bioorganic & Medicinal Chemistry Letters 2016.0
Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents
Bioorganic & Medicinal Chemistry Letters 2014.0
Synthesis and antitumor activity of novel pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5-one derivatives
European Journal of Medicinal Chemistry 2011.0
Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents
European Journal of Medicinal Chemistry 2016.0